ALEMBICLTDBSEALEMBIC LIMITED· PharmaceuticalsLowNeutral
Announced Wed, 28 Oct, 2026 · 12:45 IST

Board to approve September 2026 quarter and half-year results

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹87.88
prior close
₹87.48
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Residential Commercial Projects peers, median of 64sector-0.0%-0.2% vs sector

On the reaction day the stock moved 0.2 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.2
15m
+0.4
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3pendingpending-0.0-0.2
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 64Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Limited has informed BSE and NSE that its board will meet on 6 November 2026 to consider and approve unaudited financial results for the quarter and half-year ended 30 September 2026. The filing gives no financial figures. The trading window, closed since 1 October, will reopen 48 hours after results are declared.

Likely market impact

The results are still pending. Shareholders and the stock may react to the earnings, margins and cash flow figures when they are announced.